SCHEMBL1534475

SCHEMBL1534475

COc1ccc(C#CC(=O)c2ccccc2)c(OC)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
HSP90AA1 P07900 3/20 0.47
NTSR1 P30989 1/20 0.47
VCP P55072 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 4/20 0.36
MAPK1 P28482 1/20 0.36
APP P05067 1/20 0.36
BRD9 Q9H8M2 1/20 0.36
BRD7 Q9NPI1 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 3/20 0.35
OPRK1 P41145 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
S1PR2 O95136 1/20 0.35
HTT P42858 1/20 0.35
HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534391 0.79 HSP90AA1 (0.51) TDP1HSP90AA1NTSR1VCPMAPT
SCHEMBL1534476 0.75 POLB (0.59) POLBTDP1HSP90AA1VCPKMT2A
SCHEMBL363299 0.74 VCP (0.49) POLBHSP90AA1NTSR1VCPKMT2A
SCHEMBL1534560 0.74 HSP90AA1 (0.46) HSP90AA1NTSR1VCPMAPTAPP
SCHEMBL27167227 0.73 HSP90AA1 (0.63) POLBHSP90AA1NTSR1VCPKMT2A
SCHEMBL1534616 0.71 HSP90AA1 (0.49) POLBTDP1HSP90AA1NTSR1VCP
SCHEMBL1534428 0.71 HSP90AA1 (0.51) POLBHSP90AA1NTSR1VCPMAPT
SCHEMBL5158386 0.70 POLB (0.50) POLBTDP1KMT2AMEN1MAPT
SCHEMBL1534498 0.69 HSP90AA1 (0.50) POLBHSP90AA1NTSR1VCPKMT2A
SCHEMBL1534376 0.69 HSP90AA1 (0.50) POLBHSP90AA1NTSR1VCPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR POLB 3870/4885TDP1 1857/4885HSP90AA1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.